That is necessary, due to the fact that the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental process (jeff brown genetic sequencing stock). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're designed to do. This was an advancement almost nobody saw. However it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of financial investment opportunities in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff bezos). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back perhaps significantly prior to going greater - korean actress. I have actually been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. However that's not the big question anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown 1 biotech. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so lots of terrific personal companies on the verge of striking the general public markets And I've been working on a brand-new method for you to invest even prior to these companies go public.
This opportunity has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to reserve your spot for complimentary.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our usual beat (jeff brown prediction). And when it concerns tech investing, we leave it to the experts. The good news is, we have a number of such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown biotech pick). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big photo and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid development and developing amazing chances for financiers. I want to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown stock picks 2021. But regardless of what lots of readers might believe, this is a trend that's just getting started. Although the COVID-19 pandemic disrupted supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown tech stock 2021). Losing 2 months of manufacturing and sales actually affects the number of 5G devices are sold in the calendar year. When you consider all of that, selling 250 million units is impressive. More notably, the hold-ups caused by the pandemic produced a heap of pent-up need. And that demand is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G devices will be shipped in 2021 - last week. Which's not my only 5G forecast When I have actually discussed 5G in the past, I've described its 3 different phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services begin to be offered (jeff brown top biotech stock 2021). That's when we begin to see applications operating on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage 3 by this summer. This starts something of a virtuous cycle: The majority of people don't really care about the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of unbelievable applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities going forward will be huge. Stepping away from 5G, the next important innovation I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And throughout that time, there were actually only three business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is successfully a greenfield chance.
There's room for lots of business to exist in this space. jeff brown stock picks 2021. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can accurately predict the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is very important since the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has actually been a trial-and-error process. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug treatments produced using this technology. This was among those advancements that nearly nobody observed. But it's going to have extensive ramifications for curing illness. And, naturally, there will be a lot of financial investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back possibly substantially before going greater. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - jeff brown genetic sequencer stock. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. self-driving cars. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date as of February 2021, however we might not independently confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to select winning innovation stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional point of view on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional credibility as a stock-picker, and he effectively anticipated some of the most significant economic events of the previous 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it ideal each time, however Jeff Brown's accurate predictions have earned him legions of dedicated followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research provides several research study services with a wide range of expertises - jeff brown 1 biotech company.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - jeff brown biotech stocks. On its site, Brownstone states its mission is to offer retail investors with professional-grade research: "For too long, the finest financial investment research has actually not been offered to specific investors. It has been usually reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. black sea. The objective of Brownstone Research study is to make that kind of proprietary research study offered to any financiers wanting to get an edge in the markets. The goal is basic to provide distinct and lucrative financial investment research study found no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you understand even a bit about the market, you know that he has a credibility as a King Midas of sorts. jeff brown 2020 predictions. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. tech stock. might be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced technologies: expert system and electric vehicles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving vehicles ever. It's nothing except the automobile industry's Holy Grail. As you understand, electric lorries and self-driving automobile stocks have actually been huge this year, however the Wall Street maker has actually been big on buzz without much tangible outcome. Regardless of an extreme increase in competitors over the previous couple of years, Brown still thinks Musk has the very best opportunity of putting everything together.
tech could be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Essentially, this innovation would enable you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You merely leave the automobile and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the earnings. It sounds insane, but it could be closed than you think.